About

Sergio Monti holds a Mechanical Engineering degree from Politecnico di Milano (Italy), an MBA from Northumbria University (Newcastle-upon-Tyne, UK) and Executives Education courses at London Business School. He began his pharma career in the Technical Service Team of ACS Dobfar, a major antibiotics manufacturer, heading all new projects and investments. Mr Monti joined Lindal Group in 2008 as Sales Director, contributing to the growth of its V.A.R.I. respiratory division. In 2017, he was promoted to Plant Manager of Lindal’s Italian pharmaceutical facility.

Contributions

CONNECTIVITY

COMPLETING ITS TRANSITION FROM GENESIS TO MATURITY, BIOCORP OPENS NEW HORIZONS

As Biocorp prepares for the market launch of its connected injector pen add-on, Mallya, Eric Dessertenne and Arnaud Guillet share insights about key steps in the company’s development. The article discusses the many partnership Biocorp has entered in to, and includes a mini-interview with Sergio Monti, Plant Manager for one such partner, V.A.R.I.